1. Patterns of use of recombinant zoster vaccine among commercially-insured immunocompetent and immunocompromised adults 50–64 years old in the United States. Issue 1 (4th January 2023) Authors: Fix, Jonathan; Vielot, Nadja A.; Lund, Jennifer L.; Weber, David J.; Smith, Jennifer S.; Hudgens, Michael G.; Becker-Dreps, Sylvia Journal: Vaccine Issue: Volume 41:Issue 1(2023) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗